Parasternal Blockade and Serum Lactate in Cardiac Surgery
Serum Lactate in the Application of Parasternal Blockade in Trans and Post Anesthetic Stages in Cardiac Surgery
Instituto Mexicano del Seguro Social
86 participants
Jan 1, 2024
INTERVENTIONAL
Conditions
Summary
Serum lactate level is a key indicator of tissue perfusion. Parasternal blockade is associated with reduced postoperative inflammatory response by inhibiting stress response, leading to better outcomes. Elevated lactate levels help identify patients at risk of postoperative morbidity and mortality. This analytical cross-sectional study evaluated the association between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery in 2022 at Specialty Hospital CMNO. Patients with and without parasternal block were compared for changes in serum lactate levels during and after anesthesia within the first 24 hours.
Eligibility
Inclusion Criteria4
- Adult patients older than 18 years
- Either sex
- ASA II-III
- Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass.
Exclusion Criteria1
- Patients with pre-existing conditions that could independently affect serum lactate levels.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
In the case-control groups, patients with elevated serum lactate levels above 2 mmol/L and those who remained below this limit will be identified.
In case-control groups, obtain measurement of total postoperative fentanyl requirement.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06516432